Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight. Arrillaga-Romany I, Miller JJ. Neuro Oncol 2024 Apr 8:noae051. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Arrillaga-Romany I, Miller JJ. Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight. Neuro Oncol 2024 Apr 8:noae051. doi: 10.1093.
PMID: 38588460